|4Mar 14, 8:53 PM ET

Cvijic Christine Mikail 4

4 · Neurogene Inc. · Filed Mar 14, 2024

Insider Transaction Report

Form 4
Period: 2024-03-13
Cvijic Christine Mikail
President and CFO
Transactions
  • Award

    Common Stock

    2024-03-13+31,90352,844 total
  • Award

    Employee Stock Option (Right to buy)

    2024-03-13+53,90053,900 total
    Exercise: $36.06Exp: 2034-03-13Common Stock (53,900 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    wk-form4_1710463991.xmlPrimary

    FORM 4